Combination of flanking PTX_UTRs optimized for robust target protein expression in vascular endothelial cells and other cell types

Module for protein secretion available

Superior expression over standard mRNA constructs

IP secured technology (two patent families)



Next-generation PTX_LNP formulations for delivering PTXmRNA™ to various tissues and cell types

Formulations applicable for all different routes of administration

Scalable manufacturing

PTXcLNP enabling target gene expression on the vascular endothelium of the lung via the intravenous route

Modular lipid composition to generate novel LNPs

IP-secured technology (international patent applications 2021)